These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27755152)

  • 1. Hepatocellular carcinoma in patients with HIV.
    Dika IE; Harding JJ; Abou-Alfa GK
    Curr Opin HIV AIDS; 2017 Jan; 12(1):20-25. PubMed ID: 27755152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies?
    Gelu-Simeon M; Sobesky R; Haïm-Boukobza S; Ostos M; Teicher E; Fontaine H; Salmon-Ceron D; Meyer L; Trinchet JC; Paule B; Samuel D; Lewin M; Duclos-Vallée JC
    AIDS; 2014 Jun; 28(10):1379-91. PubMed ID: 24785953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature.
    Atkin C; Earwaker P; Pallan A; Shetty S; Punia P; Ma YT
    BMC Gastroenterol; 2017 Feb; 17(1):30. PubMed ID: 28193171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV coinfection.
    Pinato DJ; Dalla Pria A; Sharma R; Bower M
    AIDS; 2017 Mar; 31(5):603-611. PubMed ID: 28121711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
    Bruix J; Raoul JL; Sherman M; Mazzaferro V; Bolondi L; Craxi A; Galle PR; Santoro A; Beaugrand M; Sangiovanni A; Porta C; Gerken G; Marrero JA; Nadel A; Shan M; Moscovici M; Voliotis D; Llovet JM
    J Hepatol; 2012 Oct; 57(4):821-9. PubMed ID: 22727733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011.
    Di Benedetto N; Peralta M; Alvarez E; Schroder MT; Estepo C; Paz S; Fainboim H
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):38-44. PubMed ID: 24378264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients.
    Berretta M; Di Benedetto F; Dal Maso L; Cacopardo B; Nasti G; Facchini G; Bearz A; Spina M; Garlassi E; De Re V; Fiorica F; Lleshi A; Tirelli U
    Anticancer Drugs; 2013 Feb; 24(2):212-8. PubMed ID: 23197082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in HIV hepatitis C virus.
    Puoti M; Rossotti R; Garlaschelli A; Bruno R
    Curr Opin HIV AIDS; 2011 Nov; 6(6):534-8. PubMed ID: 21934618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)].
    Vennarecci G; Ettorre GM; Antonini M; Maritti M; Moricca P; D'Offizzi G; Narciso P; Lonardo MT; Boschetto A; Del Nonno F; Perracchio L; Palmieri GP; Visco G; Santoro E
    Tumori; 2003; 89(4 Suppl):159-61. PubMed ID: 12903579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010.
    Brook G; Main J; Nelson M; Bhagani S; Wilkins E; Leen C; Fisher M; Gilleece Y; Gilson R; Freedman A; Kulasegaram R; Agarwal K; Sabin C; Deacon-Adams C;
    HIV Med; 2010 Jan; 11(1):1-30. PubMed ID: 20059574
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib.
    Kawaoka T; Aikata H; Teraoka Y; Inagaki Y; Honda F; Hatooka M; Morio K; Morio R; Kobayashi T; Nagaoki Y; Nakahara T; Hiramatsu A; Tsuge M; Imamura M; Kawakami Y; Chayama K
    Oncology; 2017; 92(6):335-346. PubMed ID: 28245484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy.
    Park JG
    Clin Mol Hepatol; 2015 Sep; 21(3):287-94. PubMed ID: 26527250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study.
    Warren-Gash C; Childs K; Thornton A; Bhagani S; Demma S; Srivastava A; Leen C; Agarwal K; Rodger AJ; Sabin CA;
    Infection; 2017 Apr; 45(2):215-220. PubMed ID: 28054251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in HIV positive patients.
    Nunnari G; Berretta M; Pinzone MR; Di Rosa M; Berretta S; Cunsolo G; Malaguarnera M; Cosentino S; De Paoli P; Schnell JM; Cacopardo B
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1257-70. PubMed ID: 23047511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
    Clifford GM; Rickenbach M; Polesel J; Dal Maso L; Steffen I; Ledergerber B; Rauch A; Probst-Hensch NM; Bouchardy C; Levi F; Franceschi S;
    AIDS; 2008 Oct; 22(16):2135-41. PubMed ID: 18832877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.
    Yopp AC; Subramanian M; Jain MK; Mansour JC; Schwarz RE; Balch GC; Singal AG
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1284-90. PubMed ID: 22902759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
    Vilgrain V; Abdel-Rehim M; Sibert A; Ronot M; Lebtahi R; Castéra L; Chatellier G;
    Trials; 2014 Dec; 15():474. PubMed ID: 25472660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
    Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
    Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.